The company has announced the appointment of Marie Moores as Executive Vice President of Clinical Operations.
Moores will join LINK Medical’s United Kingdom office and support the delivery of international clinical oversight across the company’s northern European facilities. This appointment represents an important step forwards in strengthening LINK Medical’s oncology expertise, it states.
Experience within international clinical studies
Marie Moores joins LINK Medical from a specialist oncology CRO, where she was Director Clinical and Regulatory Operations for many years. She holds a degree in Clinical Research and has a longstanding experience in clinical development and regulatory strategy within the field of oncology, advanced therapies, biologics and gene therapies. She also serves the European Commission in reviewing the progress of Horizon 2020-funded clinical trials as an external expert.
“By recruiting Marie, we have added significant competence to our leadership team,” said Ola Gudmundsen, CEO at LINK Medical. “Marie’s impressive experience and knowledge within international clinical studies and regulatory affairs will greatly strengthen our customer offerings. In addition, our expansion to the UK broadens our international footprint, enabling stronger service provision to more companies looking for the LINK Advantage.”
“I am exhilarated to have been offered the opportunity to develop LINK Medical’s oncology offerings at such an important time for the organization,” said Marie Moores. “The company’s goals and values are a perfect match for my next career step, and I am looking forward to contributing to our future success while delivering the very best service to our customers.”
